Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovate (VATE) Common Equity (2016 - 2025)

Innovate has reported Common Equity over the past 16 years, most recently at -$240.1 million for Q4 2025.

  • For Q4 2025, Common Equity fell 33.09% year-over-year to -$240.1 million; the TTM value through Dec 2025 reached -$240.1 million, down 33.09%, while the annual FY2025 figure was -$240.1 million, 33.09% down from the prior year.
  • Common Equity for Q4 2025 was -$240.1 million at Innovate, down from -$215.9 million in the prior quarter.
  • Over five years, Common Equity peaked at $511.5 million in Q2 2021 and troughed at -$240.1 million in Q4 2025.
  • A 5-year average of -$76.1 million and a median of -$127.1 million in 2023 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: soared 583.47% in 2021 and later plummeted 116.76% in 2022.
  • Year by year, Common Equity stood at -$56.2 million in 2021, then plummeted by 61.21% to -$90.6 million in 2022, then tumbled by 67.44% to -$151.7 million in 2023, then fell by 18.92% to -$180.4 million in 2024, then tumbled by 33.09% to -$240.1 million in 2025.
  • Business Quant data shows Common Equity for VATE at -$240.1 million in Q4 2025, -$215.9 million in Q3 2025, and -$206.4 million in Q2 2025.